- Trials with a EudraCT protocol (141)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
141 result(s) found for: Cerebral hemorrhage.
Displaying page 1 of 8.
EudraCT Number: 2020-004746-10 | Sponsor Protocol Number: NTA1702 | Start Date*: 2021-01-27 | |||||||||||||||||||||||||||||||
Sponsor Name:The Florey Institute of Neuroscience and Mental Health | |||||||||||||||||||||||||||||||||
Full Title: STOP-MSU – Stopping haemorrhage with Tranexamic acid for hyperacute Onset Presentation including Mobile Stroke Units | |||||||||||||||||||||||||||||||||
Medical condition: Intracerebral Haemorrhage | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FI (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-006206-24 | Sponsor Protocol Number: Aivoverenvuotopotilaan tromboosipro | Start Date*: 2008-12-17 | |||||||||||
Sponsor Name:Hillbom Matti OYS/neurologian klinikka | |||||||||||||
Full Title: A blind randomized trial to compare the efficacy of intermittent pneumatic compression (IPC) with and without early anticoagulant treatment for prevention of venous thromboembolism (VTE) in patient... | |||||||||||||
Medical condition: Spontaani aivoverenvuoto | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004108-37 | Sponsor Protocol Number: 12101 | Start Date*: 2012-11-23 | |||||||||||
Sponsor Name:University of Nottingham | |||||||||||||
Full Title: Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage TICH-2 | |||||||||||||
Medical condition: Primary Intracerebral Haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) ES (Completed) HU (Completed) DK (Completed) IT (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000602-73 | Sponsor Protocol Number: LEX-206 | Start Date*: 2008-02-07 | |||||||||||||||||||||
Sponsor Name:OCTAPHARMA AG | |||||||||||||||||||||||
Full Title: Efficacy and Safety of two doses regimens of Octaplex in patients with cerebral haemorrhage related to oral anticoagulant therapy: A phase IV, prospective, randomised, open-label study. | |||||||||||||||||||||||
Medical condition: Traitement des saignements et prophylaxie péri-opératoire des accidents hémorragiques en cas de déficit acquis en facteurs de coagulation du complexe prothrombique, notamment induit par les anti-vi... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005738-23 | Sponsor Protocol Number: CBAF312X2207 | Start Date*: 2018-06-15 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A phase II, patient and investigator-blinded, randomized, placebo-controlled study to evaluate efficacy, safety and tolerability of BAF312 in patients with stroke due to intracerebral hemorrhage (ICH) | |||||||||||||
Medical condition: Intracerebral Hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002433-15 | Sponsor Protocol Number: RS200511 | Start Date*: 2021-02-15 | ||||||||||||||||||||||||||
Sponsor Name:Region Skåne | ||||||||||||||||||||||||||||
Full Title: Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948 | ||||||||||||||||||||||||||||
Medical condition: Traumatic brain injury (TBI), cerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH) and cerebral commotio. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004202-24 | Sponsor Protocol Number: F7ICH-1641 | Start Date*: 2005-04-29 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral ... | |||||||||||||
Medical condition: Acute Intracerebral Haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) SE (Completed) NO (Completed) DK (Completed) IT (Completed) BE (Completed) AT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005653-37 | Sponsor Protocol Number: ICH-VKA | Start Date*: 2009-05-29 | |||||||||||
Sponsor Name:Universityhospital of Heidelberg | |||||||||||||
Full Title: Multicenter, prospective randomized trial on the use of prothrombin complex and fresh frozen plasma in patients with intracerebral hemorrhage related to vitamin K antagonists (VKA) | |||||||||||||
Medical condition: Intracerebral hemorrhage (ICH) in patients related to vitamin K antagonists | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Suspended by CA) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000230-53 | Sponsor Protocol Number: TMC-CLV-07-02 | Start Date*: 2008-05-15 | ||||||||||||||||
Sponsor Name:The Medicines Company | ||||||||||||||||||
Full Title: The evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment | ||||||||||||||||||
Medical condition: Acute hypertension in patients who present with intracerebral hemorrhage | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004521-17 | Sponsor Protocol Number: BIT-001 | Start Date*: 2018-02-19 | |||||||||||
Sponsor Name:BIT Pharma GmbH | |||||||||||||
Full Title: A Phase IIa: single ascending dose safety, tolerability and pharmacokinetic study of NicaPlant® in aneurysmal subarachnoid haemorrhage patients undergoing aneurysm clipping | |||||||||||||
Medical condition: Aneurysmal subarachnoid haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003179-32 | Sponsor Protocol Number: ToL54304 | Start Date*: 2016-02-03 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: PREvention of Complications to Improve Outcome in elderly patients with acute Stroke. A randomised, open, phase III, clinical trial with blinded outcome assessment. | |||||||||||||||||||||||
Medical condition: Stroke (ischaemic stroke or intracerebral hemorrhage) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) HU (Completed) GR (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006006-22 | Sponsor Protocol Number: ICH01 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust [...] | |||||||||||||
Full Title: Minimally Invasive Surgery plus rt-PA for ICH Evacuation | |||||||||||||
Medical condition: intracerebral hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004121-16 | Sponsor Protocol Number: AC16141 | Start Date*: 2017-09-11 | |||||||||||
Sponsor Name:University of Edinburgh | |||||||||||||
Full Title: Start or STop Anticoagulants Randomised Trial (SoSTART) after spontaneous intracranial haemorrhage | |||||||||||||
Medical condition: Spontaneous Intracranial Haemorrhage (ICH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003190-26 | Sponsor Protocol Number: RESTART13 | Start Date*: 2013-01-14 | |||||||||||
Sponsor Name:ACCORD (Academic and Clinical Central Office for Research & Development) [...] | |||||||||||||
Full Title: REstart or STop Antithrombotics Randomised Trial (RESTART) | |||||||||||||
Medical condition: Spontaneous Intracerebral Haemorrhage (ICH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002721-18 | Sponsor Protocol Number: AC-054-203 | Start Date*: 2016-02-17 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: A prospective, multi-center, open-label, single-arm, Phase 2 study to assess the efficacy and safety of clazosentan in reversing angiographically-confirmed cerebral vasospasm in adult subjects with... | ||||||||||||||||||
Medical condition: Aneurysmal subarachnoid hemorrhage (aSAH); cerebral vasospasm | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023878-40 | Sponsor Protocol Number: 2.3 | Start Date*: 2011-12-22 |
Sponsor Name:Medical University Vienna | ||
Full Title: Influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations, cerebral oxygenation, angiographic vasospasm, delayed s... | ||
Medical condition: To demonstrate the influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations and cerebral oxygenation in patients ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002457-30 | Sponsor Protocol Number: 13.0099 | Start Date*: 2013-09-13 | |||||||||||||||||||||
Sponsor Name:St George's University of London | |||||||||||||||||||||||
Full Title: An open label randomised controlled trial investigating the effect of donepezil on regional cerebral blood flow in adults with aneurysmal subarachnoid haemorrhage. | |||||||||||||||||||||||
Medical condition: Aneurysmal subarachnoid haemorrhage Cerebral vasospasm Ischaemic stroke | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016057-17 | Sponsor Protocol Number: 23349 | Start Date*: 2011-07-14 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Gentofte Hospital | ||||||||||||||||||||||||||||||||||||||
Full Title: Behandling med nerveaktiverende medicin efter apopleksi - måling af genoptræningseffekt, patologisk træthed, muskelstyrke og knogleafkalkning | ||||||||||||||||||||||||||||||||||||||
Medical condition: Apopleksi. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002176-41 | Sponsor Protocol Number: 17HH4268 | Start Date*: 2019-09-03 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Imperial College of Science Technology and Medicine | ||||||||||||||||||||||||||||||||||||||
Full Title: PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation (PRESTIGE-AF) | ||||||||||||||||||||||||||||||||||||||
Medical condition: Ischaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhage | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) AT (Completed) FR (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002798-50 | Sponsor Protocol Number: prostacyclin | Start Date*: 2011-09-27 | |||||||||||
Sponsor Name:Rune Rasmussen | |||||||||||||
Full Title: Effect of prostacyclin infusion on cerebral vessels and metabolism in patients with subarachnoid haemorrhage | |||||||||||||
Medical condition: Vasospasm following subarachnoid hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
